Artificial Intelligence (AI) in Healthcare Market: Growth, Size, Share, and Trends

Report Code HIT 9226
Published in Dec, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals), Region- Global Forecast to 2030

Overview

The global artificial intelligence (AI) in healthcare market, valued at US$10.31 billion in 2023, is forecasted to grow at a robust CAGR of 49.1%, reaching US$14.92 billion in 2024 and an impressive US$164.16 billion by 2030. The rising incidence of chronic diseases, coupled with an increasing geriatric population, puts significant financial pressure on healthcare providers. Consequently, there is a growing need for the early detection of conditions such as dementia and cardiovascular disorders. This can be achieved by analyzing imaging data to identify patterns, which helps create personalized treatment plans.

Additionally, there is a rising demand for enhanced health services that incorporate artificial intelligence (AI), machine learning (ML), and data analytics. Moreover, growing government support through funding and investments across various regions has contributed to a heightened awareness of diagnostic imaging among individuals. Together, these factors are driving the increasing adoption of AI tools in the healthcare industry.

Artificial Intelligence (AI) in Healthcare Market

Attractive Opportunities in the Artificial Intelligence (AI) in Healthcare Market

Asia Pacific

Market growth in the Asia Pacific can be attributed to the presence of a large and growing patient population; a gradual shift towards adopting technologies like automation, data analytics, and cloud computing; and increasing spending on HCIT infrastructure.

The rapid proliferation of AI in the healthcare sector, the rising need for early disease detection, and the growing support from government and private organizations are key factors driving market growth.

Strategic partnerships and collaborations among healthcare companies and AI technology providers are expected to provide lucrative opportunities for market players.

Growth in the North American market can be attributed to the high per capita healthcare expenditure, ongoing technological developments, and large number of diagnostic procedures carried out.

Concerns regarding data privacy and the lack of interoperability between AI solutions offered by different vendors are expected to challenge the growth of this market.

Global Artificial Intelligence (AI) in Healthcare Market Dynamics

DRIVER: Significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases

The surging demand for services, expensive prescription drugs, technological advancements, and rising incidence of chronic illnesses pose significant cost challenges across the global healthcare industry. Healthcare providers need to optimize their operations strategically by reallocating their resources, including staffing, medical devices, and operational dimensions, by adopting AI. According to the Centre for Economic Policy Research, the widespread adoption of Al technology in healthcare could result in annual savings ranging from USD 200 to USD 360 billion over the next five years, constituting 5% to 10% of healthcare spending. This presents a huge financial opportunity while providing increased quality of patient care, highlighting the significant role of AI in reducing healthcare costs and elevating the overall value of healthcare.

Al-based tools can significantly reduce healthcare spending by minimizing manual labor and addressing inefficiencies in care delivery, overtreatment, and improper care. They streamline operations and improve precision in resource allocation, thus contributing to a more efficient and cost-effective healthcare ecosystem.

RESTRAINT: Lack of standardized frameworks for AI and ML technologies

The dynamic nature of Al algorithms introduces significant regulatory challenges, particularly concerning data privacy, algorithmic bias, and accountability, with the frameworks & guidelines often being ambiguous & unclear. This lack of clarity in regulations creates hesitancy and discourages stakeholders from thoroughly exploring and adopting AI-based solutions that could otherwise offer significant benefits to the healthcare industry. Regulatory agencies such as the FDA in the US have issued guidance documents to identify when software or mobile apps are classified as medical devices. However, regulating medical software is still controversial, shaped by evolving standards and subjective interpretations. Similarly, in the European Union, software with a medical purpose may be classified as a medical device; however, the evaluation process is complex because it is not immediately apparent how these criteria apply to AI-based software.

These unclear regulatory guidelines create significant barriers to innovation among market players, hindering and resulting in higher development costs, extended timelines, and a slower pace of progress in the Al healthcare market. Therefore, it is critical to address these challenges to unlock Al's immense potential for revolutionizing healthcare and realize its benefits for all stakeholders.

 

OPPORTUNITY: Strategic partnerships and collaborations among healthcare companies and AI technology providers

The increasing number of partnerships and collaborations across diverse sectors within the healthcare industry emerge as a significant driver for the AI in healthcare market. This collaborative paradigm involves technology firms, healthcare providers, research institutions, and pharmaceutical companies, fostering synergistic efforts to address the multifaceted challenges in healthcare. By combining technological expertise with clinical insights, these collaborations ensure the seamless integration of Al technologies into diagnostics, treatment planning, patient care, and administrative processes. The collective approach enhances algorithmic precision through extensive datasets and navigates regulatory complexities, propelling the AI in healthcare market toward transformative growth and improved healthcare outcomes. The rising recognition of the advantages provided by Al techniques, coupled with their extensive applications, has boosted adoption in the healthcare market. Key players in healthcare are strategically forging partnerships and collaborations with leading Al technology providers to pioneer innovative Al-based solutions tailored for healthcare applications. For instance, in December 2023, OU Health (US) and Siemens Healthineers (US) successfully established a 10-year value partnership to enhance healthcare in Oklahoma. The partnership included advanced imaging and laboratory equipment, such as the 7-t Tesla MRI scanner and photon-counting CT system, improving diagnostic capabilities. The partnership extended to using Siemens Healthineers' mobile technology for preventive screenings and diagnostics, mainly benefiting rural and underserved communities.

CHALLENGES: Concerns regarding data privacy

Data privacy concerns have limited the adoption of artificial intelligence (AI) in the healthcare industry. Patient health data is protected by federal laws in many countries, and any breach or failure to maintain data integrity can result in legal and financial penalties. AI-based tools require access to multiple health datasets, which must comply with all data security protocols implemented by governments and regulatory authorities. However, the consolidation of patient data in vendor data centers has created a challenge, as such data centers are vulnerable to cyber-attacks and breaches. If left unaddressed, these concerns can erode patient trust, pose regulatory obstacles, and inflict reputational damage on healthcare providers and AI vendors. The HIPAA Journal compiled healthcare data breach statistics when the Department of Health and Human Services’ Office for Civil Rights started publishing summaries of healthcare data breaches on its website. The figure below shows the records of healthcare breaches, further underscoring the need for robust data governance and privacy-enhancing technologies when utilizing AI-based tools in the healthcare industry.

Global Artificial Intelligence (AI) in Healthcare Market Ecosystem Analysis

The ecosystem of the artificial intelligence (AI) in healthcare market comprises network connectivity and hardware providers, AI software and service providers, cloud service providers, government and regulatory bodies, non-profit organizations, start-ups, and end users such as hospitals, diagnostic and imaging centers, and payers, among others.

Artificial Intelligence (AI) in Healthcare Market
 

The machine learning segment accounted for a substantial share of the artificial intelligence (AI) in healthcare market, by tool, in 2023.

Based on tools, the AI in healthcare market is segmented into machine learning, natural language processing, generative AI, computer vision, image analysis, and other tools. In 2023, the machine learning segment accounted for the largest share of the market. The large share of this segment can be attributed to the enormous availability of data, also called big data, and the increasing adoption of ML by hospitals, research centers, and other healthcare institutions to improve patient health. ML is being implemented in healthcare to deal with large volumes of data, streamline hospital administrative processes, map and treat infectious diseases, and personalize medical treatments. These advantages are poised to increase the adoption of ML in the healthcare industry.

The diagnosis & early detection accounted to hold the largest share in the Artificial Intelligence (AI) in healthcare market, by function.

Diagnosis & early detection, treatment planning & personalization, patient engagement & remote monitoring, post-treatment surveillance & survivorship care, pharmacy management, data management & analytics, and administrative function make up the Artificial Intelligence (AI) in healthcare market, by function. The diagnosis & early detection accounted for the largest share of the Artificial Intelligence (AI) in healthcare market in 2023. Significant share of this segment is attributed to its ability to analyze vast datasets with high accuracy, enabling early identification of diseases such as cancer, cardiovascular conditions, and neurological disorders. AI-powered tools like medical imaging analysis, natural language processing for clinical notes, and predictive analytics enhance the precision and speed of diagnoses, reducing diagnostic errors and improving patient outcomes. Additionally, the increasing prevalence of chronic diseases and advancements in AI technologies, such as deep learning algorithms, further propel the demand for AI-driven diagnostic solutions.

North America dominated the AI in healthcare market in 2023.

The AI in healthcare market is studied for the five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The North American region dominated the market due to the high per capita healthcare expenditure, ongoing technological developments, particularly in machine learning & deep learning, the rising demand for precision medicine, and the favorable reimbursement scenario. The surging number of patients with chronic disorders and significant investments by government & private entities toward healthcare information technology further propel the growth. Moreover, the competitive scenario in North America motivates key market players to develop innovative tools, driving continuous growth in service offerings.

HIGHEST CAGR MARKET IN 2023
US FASTEST GROWING MARKET IN THE REGION
Artificial Intelligence (AI) in Healthcare Market

Recent Developments of Artificial Intelligence (AI) in Healthcare Market

  • In July 2024, Microsoft collaborated with Mass General Brigham and the University of Wisconsin–Madison to advance AI models for medical imaging related to more than 23,000 conditions to enhance radiologist efficiency and improve patient outcomes.
  • In January 2024, Siemens and Amazon Web Services (AWS) collaborated to democratize generative AI in software development, integrating Amazon Bedrock into Siemens' Mendix low-code platform. This collaboration aimed to empower domain experts across industries to create and enhance applications easily using advanced generative AI.
  • In November 2023, Koninklijke Philips N.V. collaborated with Vestre Viken Health Trust in Norway to deploy its AI Manager platform to enhance radiology workflows. The AI-enabled bone fracture application streamlined diagnoses, allowing radiologists to focus on complex cases. This initiative, spanning 30 hospitals and serving around 3.8 million people, marked Philips' most extensive AI deployment in Europe, contributing to improved patient care and accelerated diagnostic processes.
  • In November 2023, Koninklijke Philips N.V. received a second round of funding totaling USD 60 million from the Bill & Melinda Gates Foundation to expedite the innovation and accelerate the global adoption of AI algorithms on its Lumify Handheld Ultrasound.

Key Market Players

KEY PLAYERS IN THE ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Artificial Intelligence (AI) in Healthcare Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Million/Billion (USD)
Segments covered Offering, Function, Application, Deployment, Tools, End User
Geographies covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

 

Key Questions Addressed by the Report

Which are the top industry players in the global AI in healthcare market?
The top market players include Koninklijke Philips N.V. (Netherlands), Microsoft (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Veradigm LLC (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), Amazon Web Services, Inc. (US), SOPHiA GENETICS (US), Riverian Technologies (US), Terarecon (ConcertAI) (US), 3M (US), Tempus (US), and Viz.ai (US).
Which offerings have been included in the AI in healthcare market report?
The report includes the following components: Integrated solutions, Niche/point solutions, AI technology, and Services.
Which region dominates the global AI in healthcare market?
North America holds a substantial share of the global AI in healthcare market. The Asia Pacific region is expected to register the highest growth rate during the forecast period.
Which end users have been included in the AI in healthcare market report?
The report contains the following industry segments: Hospitals & Ambulatory Surgical Centers, Diagnostic & Imaging Centers, Academic & Research Centers, and Other End Users.
What is the total CAGR expected to be recorded for the AI in healthcare market during 2024–2030?
The market is expected to record a CAGR of 49.1% from 2024–2029.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Artificial Intelligence (AI) in Healthcare Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
57
RESEARCH METHODOLOGY
65
EXECUTIVE SUMMARY
79
PREMIUM INSIGHTS
85
MARKET OVERVIEW
89
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing need for early detection and diagnosis
    - Exponential growth in data volume and complexity due to surging adoption of digital technologies
    - Significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases
    - Rapid proliferation of AI in healthcare sector
    - Growing need for improvised healthcare services
    RESTRAINTS
    - Reluctance among medical practitioners to adopt AI-based technologies
    - Shortage of skilled AI professionals handling AI-powered solutions
    - Lack of standardized frameworks for AL and ML technologies
    OPPORTUNITIES
    - Increasing use of AI-powered solutions in elderly care
    - Increasing focus on developing human-aware AI systems
    - Strategic partnerships and collaborations among healthcare companies and AI technology providers
    CHALLENGES
    - Inaccurate predictions due to scarcity of high-quality healthcare data
    - Concerns regarding data privacy
    - Lack of interoperability between AI solutions offered by different vendors
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Machine learning (ML) & deep learning
    - Natural language processing (NLP)
    - Computer vision (CV)
    COMPLEMENTARY TECHNOLOGIES
    - Cloud computing
    - Digital twins
    - Robotic process automation (RPA)
    ADJACENT TECHNOLOGIES
    - Blockchain
    - Augmented and virtual reality (AR/VR)
    - Internet of things (IoT)
  • 5.5 INDUSTRY TRENDS
    SHIFT TOWARD PERSONALIZED MEDICINE
    AI IN DIAGNOSTICS AND IMAGING
  • 5.6 PRICING ANALYSIS
    INDICATIVE PRICING OF AI IN HEALTHCARE SOFTWARE, BY DEPLOYMENT MODEL (QUALITATIVE)
    INDICATIVE PRICE TREND, BY REGION
  • 5.7 VALUE CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 PATENT ANALYSIS
  • 5.10 KEY CONFERENCES & EVENTS, 2024–2025
  • 5.11 CASE STUDY ANALYSIS
    BIOBEAT LAUNCHED HOME-BASED REMOTE PATIENT MONITORING KIT DURING PEAK WAVE OF COVID-19
    MICROSOFT COLLABORATED WITH CLEVELAND CLINIC TO APPLY PREDICTIVE AND ADVANCED ANALYTICS TO IDENTIFY POTENTIAL AT-RISK PATIENTS UNDER ICU CARE
    TGEN COLLABORATED WITH INTEL CORPORATION AND DELL TECHNOLOGIES TO ASSIST PHYSICIANS AND RESEARCHERS IN ACCELERATING DIAGNOSIS AND TREATMENT AT LOWER COSTS
    GE HEALTHCARE IMPROVED PATIENT OUTCOMES BY REDUCING WORKFLOW PROCESSING TIME USING MEDICAL IMAGING DATA
  • 5.12 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
    - North America
    - Europe
    - Asia Pacific
    - Middle East & Africa
    - Latin America
  • 5.13 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.15 END-USER ANALYSIS
    UNMET NEEDS
    END-USER EXPECTATIONS
  • 5.16 AI IN HEALTHCARE BUSINESS MODELS
    SOFTWARE-AS-A-SERVICE (SAAS) MODEL
    LICENSING MODEL
    REVENUE SHARING/OUTCOME-BASED MODEL
    FREEMIUM MODEL
    AI-AS-A-SERVICE (AIAAS) MODEL
    PARTNERSHIP/REVENUE-SHARING MODEL
    HYBRID MODELS
    PAY-PER-USE MODELS
  • 5.17 INVESTMENT & FUNDING SCENARIO
  • 5.18 IMPACT OF GENERATIVE AI ON AI IN HEALTHCARE MARKET
    INTRODUCTION
    MARKET POTENTIAL OF GEN AI IN HEALTHCARE
    - Key use cases of Gen AI
    CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
    - Eka Care leveraging generative AI for improved health outcomes
    INTERCONNECTED AND ADJACENT ECOSYSTEMS
    - AI in healthcare IT
    - AI in medical diagnostics
    - AI in oncology
    - AI in clinical trials
    - AI in drug discovery
    USER READINESS & IMPACT ASSESSMENT
    - User readiness
    - Impact assessment
AI IN HEALTHCARE MARKET, BY OFFERING
145
  • 6.1 INTRODUCTION
  • 6.2 INTEGRATED SOLUTIONS
    RISING WORKFORCE CHALLENGES AND COST PRESSURES TO DRIVE ADOPTION
  • 6.3 NICHE/POINT SOLUTIONS
    TARGETED AI SOLUTIONS TRANSFORMING PRECISION CARE AND EFFICIENCY IN HEALTHCARE TO BOOST MARKET
  • 6.4 AI TECHNOLOGIES
    ABILITY OF CORE AI TECHNOLOGIES TO DRIVE PRECISION, EFFICIENCY, AND INNOVATION TO SUPPORT MARKET GROWTH
  • 6.5 SERVICES
    NEED FOR EMPOWERING NON-CLINICAL HEALTHCARE OPERATIONS TO ACCELERATE MARKET GROWTH
AI IN HEALTHCARE MARKET, BY FUNCTION
151
  • 7.1 INTRODUCTION
  • 7.2 DIAGNOSIS & EARLY DETECTION
    PRE-SCREENING
    - Early detection, better outcomes, and cost-effective care associated with pre-screening to boost market
    IVD
    - IVD market: By technology
    - IVD market: By application
    DIAGNOSTIC IMAGING
    - Diagnostic imaging market: By application
    - Diagnostic imaging market: By modality
    RISK ASSESSMENT & PATIENT STRATIFICATION
    - AI-driven risk assessment and patient stratification to enhance healthcare efficiency, outcomes, and personalized care
    DRUG ALLERGY ALERTING
    - Ability of AI-enhanced drug allergy alerting to improve accuracy, patient safety, and personalized care in healthcare to boost market
    OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS
  • 7.3 TREATMENT PLANNING & PERSONALIZATION
    PERSONALIZED TREATMENT PLANNING
    - Precision medicine & genomic analysis
    - Predictive models for treatment response
    - Treatment recommendation systems
    PHARMACOLOGICAL THERAPY
    - Drug response prediction
    - Dosing & administration
    - Other pharmacological therapy functions
    SURGICAL THERAPY
    - Preoperative imaging & 3D modeling
    - Intraoperative guidance & robotics
    - Postoperative analysis & recovery
    RADIATION THERAPY
    - Motion synchronization & auto contouring
    - Real-time adaptive treatment delivery
    - Response assessment & quality assurance
    - Other radiation therapy functions
    BEHAVIORAL THERAPY & PSYCHOTHERAPY
    - Virtual counseling & chatbots
    - Progress monitoring & feedback
    - Follow-up & long-term support
    IMMUNOTHERAPY
    - Real-time patient data monitoring
    - Response & side-effect prediction
    - Relapse prediction & long-term management
    OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS
  • 7.4 PATIENT ENGAGEMENT & REMOTE MONITORING
    SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE
    - Rising prevalence of chronic diseases to drive market growth
    TELEHEALTH & REMOTE PATIENT MONITORING
    - Ability to monitor and evaluate patients remotely to boost market demand
    HEALTHCARE ASSISTANCE ROBOTS
    - Advancements in robotics and artificial intelligence (AI) to boost market demand
    MEDICATION REMINDERS
    - Increasing adoption of smartphone applications and IoT devices to surge market demand
    PATIENT EDUCATION & EMPOWERMENT
    - Need to improve treatment adherence and enhance self-management to drive market growth
    OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS
  • 7.5 POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE
    RECURRENCE MONITORING
    - Need to predict recurrence of cancer to drive market
    LONG-TERM OUTCOME PREDICTION
    - Ability to predict long-term health outcomes and enhance patient care to drive market
    MENTAL HEALTH & SUPPORT SYSTEMS
    - Need to help patients cope with mental strain to drive market
  • 7.6 PHARMACY MANAGEMENT
    EPRESCRIBING
    - Need to improve safety and efficiency in prescribing to drive market
    MEDICATION MANAGEMENT
    - Ability to predict adverse drug reactions by patient data analysis to drive market
    PHARMACY AUDIT & ANALYSIS
    - Need for effective and efficient operation of pharmacies to drive market
    OTHER PHARMACY MANAGEMENT FUNCTIONS
  • 7.7 DATA MANAGEMENT & ANALYTICS
    ABILITY OF DATA MANAGEMENT & ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS MAKE INFORMED DECISIONS TO BOOST MARKET
  • 7.8 ADMINISTRATIVE
    PATIENT REGISTRATION & SCHEDULING
    - Need to optimize patient registration process to drive market
    PATIENT ELIGIBILITY & AUTHORIZATION
    - Need to reduce administrative burden to drive market
    BILLING & CLAIMS MANAGEMENT
    - Need to make billing process more accurate, efficient, and transparent to drive market
    WORKFORCE MANAGEMENT
    - Need for effective staff management to drive market
    SUPPLY CHAIN & INVENTORY MANAGEMENT
    - Ability to make better procurement decisions to drive market
    COMPLIANCE & DOCUMENTATION
    - Need to reduce manual paperwork and errors to drive market
    HEALTHCARE WORKFLOW MANAGEMENT
    - Need to optimize and automate processes within healthcare facilities to drive market
    ASSET MANAGEMENT
    - Ability to optimize use and allocation of resources to drive market
    CUSTOMER RELATIONSHIP MANAGEMENT
    - Enhancing patient engagement and retention through AI-driven CRM systems to boost market
    FRAUD DETECTION & RISK MANAGEMENT
    - Need to enhance security in healthcare systems to drive market demand
    CYBERSECURITY
    - Enhancing healthcare cybersecurity with AI-driven threat detection and risk management to fuel growth
    OTHER ADMINISTRATIVE FUNCTIONS
AI IN HEALTHCARE MARKET, BY APPLICATION
222
  • 8.1 INTRODUCTION
  • 8.2 CLINICAL APPLICATIONS
    ABILITY OF AI TO IMPROVE DIAGNOSTICS, TREATMENT, AND PATIENT CARE TO DRIVE MARKET GROWTH
  • 8.3 NON-CLINICAL APPLICATIONS
    ABILITY OF AI TO REDUCE ADMINISTRATIVE BURDENS AND ENSURE BETTER RESOURCE ALLOCATION TO FUEL GROWTH
AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL
227
  • 9.1 INTRODUCTION
  • 9.2 ON-PREMISE MODELS
    ENHANCED DATA SECURITY AND COMPLIANCE TO PROPEL ADOPTION OF ON-PREMISE AI MODELS
  • 9.3 CLOUD-BASED MODELS
    SCALABILITY AND AUTOMATION OF CLOUD-BASED AI PLATFORMS TO RESHAPE HEALTHCARE DELIVERY GLOBALLY
  • 9.4 HYBRID MODELS
    FLEXIBILITY FOR DIVERSE APPLICATIONS TO BOOST DEMAND FOR HYBRID MODELS
    ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TOOL
ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TOOL
232
  • 10.1 INTRODUCTION
  • 10.2 MACHINE LEARNING
    DEEP LEARNING
    - Convolutional neural networks (CNN)
    - Recurrent neural networks (RNN)
    - Generative adversarial networks (GAN)
    - Graph neural networks (GNN)
    - Other deep learning tools
    SUPERVISED LEARNING
    - Need to drive precision and efficiency in healthcare to support adoption of supervised learning tools
    REINFORCEMENT LEARNING
    - Wide usage of reinforcement learning models for real-time and adaptive healthcare solutions to support market growth
    UNSUPERVISED LEARNING
    - Ability of unsupervised learning to drive innovation in healthcare analytics to propel market
    OTHER MACHINE LEARNING TOOLS
  • 10.3 NATURAL LANGUAGE PROCESSING (NLP)
    SENTIMENT ANALYSIS
    - Enhanced patient experience and operational insights to spur demand for sentiment analysis
    PATTERN & IMAGE RECOGNITION
    - Increased precision in clinical decision-making associated with pattern & image recognition to aid market
    AUTO CODING
    - Advantages such as improved medical billing and administrative efficiency to boost market
    CLASSIFICATION & CATEGORIZATION
    - Ability of classification & categorization to organize healthcare data for better outcomes to propel market
    TEXT ANALYTICS
    - Ability to transform unstructured data into actionable healthcare insights to fuel growth
    SPEECH RECOGNITION
    - Improved speech recognition advancing real-time documentation and accessibility to drive demand
  • 10.4 CONTEXT-AWARE COMPUTING
    DEVICE CONTEXT
    - Real-time monitoring and decision-making to contribute to market growth
    USER CONTEXT
    - Personalized healthcare and adaptive workflows to drive demand
    PHYSICAL CONTEXT
    - Location-based services associated with physical context to generate demand
  • 10.5 GENERATIVE AI
    ABILITY OF GENERATIVE AI MODELS TO MIMIC DISEASE PROGRESSION TO DRIVE MARKET
  • 10.6 COMPUTER VISION
    ABILITY TO DETECT ABNORMALITIES SUCH AS TUMORS TO FUEL ADOPTION
  • 10.7 IMAGE ANALYSIS
    STREAMLINING DOCUMENT MANAGEMENT TO PROPEL MARKET
AI IN HEALTHCARE MARKET, BY END USER
257
  • 11.1 INTRODUCTION
  • 11.2 HEALTHCARE PROVIDERS
    HOSPITALS & CLINICS
    - Growing need to improve profitability of healthcare to drive use of AI-based healthcare solutions in hospitals
    AMBULATORY CARE CENTERS
    - Supportive government norms and incentives for HCIT solutions and services to drive market growth
    HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES
    - Growing need for long-term home care to drive market growth
    DIAGNOSTIC & IMAGING CENTERS
    - Growing burden of various chronic diseases to propel market growth
    PHARMACIES
    - Advantages of workflow improvements and error reduction to drive AI-based healthcare solution adoption in pharmacies
    OTHER HEALTHCARE PROVIDERS
  • 11.3 HEALTHCARE PAYERS
    PUBLIC PAYERS
    - Focus on developing outcome-based payment models to drive demand for payer solutions
    PRIVATE PAYERS
    - Possible increases in operational efficiency to boost demand among private payers
  • 11.4 PATIENTS
    RISE IN USE OF AI IN MENTAL HEALTH SUPPORT APPLICATIONS THROUGH CHATBOTS AND VIRTUAL THERAPISTS TO BOOST MARKET
  • 11.5 OTHER END USERS
AI IN HEALTHCARE MARKET, BY REGION
273
  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Rising adoption of advanced medical imaging and regulatory support to drive market
    CANADA
    - Growing burden of chronic diseases and research grants for AI to drive market growth
  • 12.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Advanced healthcare system and government efforts to drive growth
    UK
    - Government support and new AI platform emergence to boost market
    FRANCE
    - Thriving AI ecosystem and strategic partnerships to boost healthcare innovation
    ITALY
    - Regulatory reforms, strategic investments, and aging population to propel growth
    SPAIN
    - Established network of research centers to propel market
    REST OF EUROPE
  • 12.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Expanding AI applications in medical imaging and diagnostics to drive market growth
    JAPAN
    - Strong healthcare infrastructure to drive uptake of advanced AI
    INDIA
    - Favorable government initiatives for R&D investments to drive market
    REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - AI initiatives to drive healthcare innovation and accessibility
    MEXICO
    - AI to revolutionize healthcare delivery and outcomes
    REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - AI-driven innovations and rising healthcare investments to propel market growth
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
614
  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET
  • 13.3 REVENUE ANALYSIS, 2019–2023
  • 13.4 MARKET SHARE ANALYSIS, 2023
    RANKING OF KEY MARKET PLAYERS
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Application footprint
    - Tool footprint
    - Function footprint
    - Offering footprint
    - Deployment footprint
    - End-user footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 13.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 13.8 BRAND/PRODUCT COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
640
  • 14.1 KEY PLAYERS
    KONINKLIJKE PHILIPS N.V.
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    MICROSOFT CORPORATION
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    NVIDIA CORPORATION
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    SIEMENS HEALTHINEERS AG
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    GE HEALTHCARE
    - Business overview
    - Products & services offered
    - Recent developments
    EPIC SYSTEMS CORPORATION
    - Business overview
    - Products & services offered
    - Recent developments
    ORACLE
    - Business overview
    - Products & services offered
    - Recent developments
    VERADIGM LLC
    - Business overview
    - Products & services offered
    - Recent developments
    AMAZON WEB SERVICES, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    MERATIVE (IBM)
    - Business overview
    - Products & services offered
    - Recent developments
    MEDTRONIC
    - Business overview
    - Products & services offered
    - Recent developments
    GOOGLE
    - Business overview
    - Products & services offered
    - Recent developments
    SOPHIA GENETICS
    - Business overview
    - Products & services offered
    - Recent developments
    JOHNSON & JOHNSON SERVICES, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    TEMPUS
    - Business overview
    - Products & services offered
    - Recent developments
    TERARECON (CONCERTAI)
    - Business overview
    - Products & services offered
    - Recent developments
    3M
    - Business overview
    - Products & services offered
    - Recent developments
    COGNIZANT
    - Business overview
    - Products & services offered
    - Recent developments
    VIZ.AI, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    RIVERAIN TECHNOLOGIES
    - Business overview
    - Products & services offered
    - Recent developments
  • 14.2 OTHER PLAYERS
    QVENTUS
    QURE.AI
    ATOMWISE INC.
    ENLITIC
    SEGMED
APPENDIX
726
  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 2 AI IN HEALTHCARE MARKET: RISK ASSESSMENT
  • TABLE 3 AI IN HEALTHCARE MARKET: IMPACT ANALYSIS
  • TABLE 4 AI IN HEALTHCARE MARKET: AVERAGE SELLING PRICE, BY REGION (2021–2023)
  • TABLE 5 COMPANIES AND THEIR ROLES IN AI IN HEALTHCARE ECOSYSTEM
  • TABLE 6 AI IN HEALTHCARE MARKET: INNOVATIONS AND PATENT REGISTRATIONS
  • TABLE 7 AI IN HEALTHCARE MARKET: LIST OF CONFERENCES & EVENTS, 2024–2025
  • TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • TABLE 13 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 14 UNMET NEEDS IN AI IN HEALTHCARE MARKET
  • TABLE 15 END-USER EXPECTATIONS IN AI IN HEALTHCARE MARKET
  • TABLE 16 AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 17 AI IN HEALTHCARE MARKET FOR INTEGRATED SOLUTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 18 AI IN HEALTHCARE MARKET FOR NICHE/POINT SOLUTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 19 AI IN HEALTHCARE MARKET FOR AI TECHNOLOGIES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 20 AI IN HEALTHCARE MARKET FOR SERVICES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 21 AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 22 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 23 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 24 AI IN HEALTHCARE MARKET FOR PRE-SCREENING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 25 AI IN HEALTHCARE MARKET FOR IVD, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 26 AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 27 AI IN HEALTHCARE MARKET FOR IMMUNOASSAYS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 28 AI IN HEALTHCARE MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 29 AI IN HEALTHCARE MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 30 AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 31 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS & INTERPRETATION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 32 AI IN HEALTHCARE MARKET FOR BIOMARKER DISCOVERY & ANALYSIS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 33 AI IN HEALTHCARE MARKET FOR OTHER IVD APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 34 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 35 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 36 AI IN HEALTHCARE MARKET FOR DISEASE INTERPRETATION & REPORT ANALYSIS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 37 AI IN HEALTHCARE MARKET FOR IMAGE CAPTIONING & ANNOTATION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 38 AI IN HEALTHCARE MARKET FOR IMAGE RECONSTRUCTION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 39 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 40 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 41 AI IN HEALTHCARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2022–2030 (USD MILLION)
  • TABLE 42 AI IN HEALTHCARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY REGION, 2022–2030 (USD MILLION)
  • TABLE 43 AI IN HEALTHCARE MARKET FOR X-RAY IMAGING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 44 AI IN HEALTHCARE MARKET FOR ULTRASOUND, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 45 AI IN HEALTHCARE MARKET FOR NUCLEAR IMAGING (PET & SPECT), BY REGION, 2022–2030 (USD MILLION)
  • TABLE 46 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING MODALITIES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 47 AI IN HEALTHCARE MARKET FOR RISK ASSESSMENT & PATIENT STRATIFICATION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 48 AI IN HEALTHCARE MARKET FOR DRUG ALLERGY ALERTING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 49 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 50 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 51 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 52 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 53 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 54 AI IN HEALTHCARE MARKET FOR PRECISION MEDICINE & GENOMIC ANALYSIS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 55 AI IN HEALTHCARE MARKET FOR PREDICTIVE MODELS FOR TREATMENT RESPONSE, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 56 AI IN HEALTHCARE MARKET FOR TREATMENT RECOMMENDATION SYSTEMS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 57 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 58 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 59 AI IN HEALTHCARE MARKET FOR DRUG RESPONSE PREDICTION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 60 AI IN HEALTHCARE MARKET FOR DOSING & ADMINISTRATION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 61 AI IN HEALTHCARE MARKET FOR OTHER PHARMACOLOGICAL THERAPY FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 62 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 63 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 64 AI IN HEALTHCARE MARKET FOR PREOPERATIVE IMAGING & 3D MODELING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 65 AI IN HEALTHCARE MARKET FOR INTRAOPERATIVE GUIDANCE & ROBOTICS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 66 AI IN HEALTHCARE MARKET FOR POSTOPERATIVE ANALYSIS & RECOVERY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 67 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 68 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 69 AI IN HEALTHCARE MARKET FOR MOTION SYNCHRONIZATION & AUTO CONTOURING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 70 AI IN HEALTHCARE MARKET FOR REAL-TIME ADAPTIVE TREATMENT DELIVERY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 71 AI IN HEALTHCARE MARKET FOR RESPONSE ASSESSMENT & QUALITY ASSURANCE, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 72 AI IN HEALTHCARE MARKET FOR OTHER RADIATION THERAPY FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 73 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 74 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 75 AI IN HEALTHCARE MARKET FOR VIRTUAL COUNSELING & CHATBOTS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 76 AI IN HEALTHCARE MARKET FOR PROGRESS MONITORING & FEEDBACK, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 77 AI IN HEALTHCARE MARKET FOR FOLLOW-UP & LONG-TERM SUPPORT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 78 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 79 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 80 AI IN HEALTHCARE MARKET FOR REAL-TIME PATIENT DATA MONITORING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 81 AI IN HEALTHCARE MARKET FOR RESPONSE & SIDE-EFFECT PREDICTION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 82 AI IN HEALTHCARE MARKET FOR RELAPSE PREDICTION & LONG-TERM MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 83 AI IN HEALTHCARE MARKET FOR OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 84 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 85 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 86 AI IN HEALTHCARE MARKET FOR SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 87 AI IN HEALTHCARE MARKET FOR TELEHEALTH & REMOTE PATIENT MONITORING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 88 AI IN HEALTHCARE MARKET FOR HEALTHCARE ASSISTANCE ROBOTS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 89 AI IN HEALTHCARE MARKET FOR MEDICATION REMINDERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 90 AI IN HEALTHCARE MARKET FOR PATIENT EDUCATION & EMPOWERMENT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 91 AI IN HEALTHCARE MARKET FOR OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 92 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 93 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 94 AI IN HEALTHCARE MARKET FOR RECURRENCE MONITORING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 95 AI IN HEALTHCARE MARKET FOR LONG-TERM OUTCOME PREDICTION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 96 AI IN HEALTHCARE MARKET FOR MENTAL HEALTH & SUPPORT SYSTEMS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 97 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 98 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 99 AI IN HEALTHCARE MARKET FOR EPRESCRIBING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 100 AI IN HEALTHCARE MARKET FOR MEDICATION MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 101 AI IN HEALTHCARE MARKET FOR PHARMACY AUDIT & ANALYSIS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 102 AI IN HEALTHCARE MARKET FOR OTHER PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 103 AI IN HEALTHCARE MARKET FOR DATA MANAGEMENT & ANALYTICS FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 104 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 105 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 106 AI IN HEALTHCARE MARKET FOR PATIENT REGISTRATION & SCHEDULING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 107 AI IN HEALTHCARE MARKET FOR PATIENT ELIGIBILITY & AUTHORIZATION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 108 AI IN HEALTHCARE MARKET FOR BILLING & CLAIMS MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 109 AI IN HEALTHCARE MARKET FOR WORKFORCE MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 110 AI IN HEALTHCARE MARKET FOR SUPPLY CHAIN & INVENTORY MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 111 AI IN HEALTHCARE MARKET FOR COMPLIANCE & DOCUMENTATION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 112 AI IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 113 AI IN HEALTHCARE MARKET FOR ASSET MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 114 AI IN HEALTHCARE MARKET FOR CUSTOMER RELATIONSHIP MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 115 AI IN HEALTHCARE MARKET FOR FRAUD DETECTION & RISK MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 116 AI IN HEALTHCARE MARKET FOR CYBERSECURITY, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 117 AI IN HEALTHCARE MARKET FOR OTHER ADMINISTRATIVE FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 118 AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 119 AI IN HEALTHCARE MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 120 AI IN HEALTHCARE MARKET FOR NON-CLINICAL APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 121 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 122 AI IN HEALTHCARE MARKET FOR ON-PREMISE MODELS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 123 AI IN HEALTHCARE MARKET FOR CLOUD-BASED MODELS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 124 AI IN HEALTHCARE MARKET FOR HYBRID MODELS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 125 AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 126 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 127 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 128 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 129 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 130 AI IN HEALTHCARE MARKET FOR CONVULATIONAL NEURAL NETWORKS (CNN), BY REGION, 2022–2030 (USD MILLION)
  • TABLE 131 AI IN HEALTHCARE MARKET FOR RECURRENT NEURAL NETWORKS (RNN), BY REGION, 2022–2030 (USD MILLION)
  • TABLE 132 AI IN HEALTHCARE MARKET FOR GENERATIVE ADVERSARIAL NETWORKS (GAN), BY REGION, 2022–2030 (USD MILLION)
  • TABLE 133 AI IN HEALTHCARE MARKET FOR GRAPH NEURAL NETWORKS (GNN), BY REGION, 2022–2030 (USD MILLION)
  • TABLE 134 AI IN HEALTHCARE MARKET FOR OTHER DEEP LEARNING TOOLS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 135 AI IN HEALTHCARE MARKET FOR SUPERVISED LEARNING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 136 AI IN HEALTHCARE MARKET FOR REINFORCEMENT LEARNING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 137 AI IN HEALTHCARE MARKET FOR UNSUPERVISED LEARNING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 138 AI IN HEALTHCARE MARKET FOR OTHER MACHINE LEARNING TOOLS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 139 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 140 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY REGION, 2022–2030 (USD MILLION)
  • TABLE 141 AI IN HEALTHCARE MARKET FOR SENTIMENT ANALYSIS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 142 AI IN HEALTHCARE MARKET FOR PATTERN & IMAGE RECOGNITION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 143 AI IN HEALTHCARE MARKET FOR AUTO CODING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 144 AI IN HEALTHCARE MARKET FOR CLASSIFICATION & CATEGORIZATION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 145 AI IN HEALTHCARE MARKET FOR TEXT ANALYTICS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 146 AI IN HEALTHCARE MARKET FOR SPEECH RECOGNITION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 147 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 148 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 149 AI IN HEALTHCARE MARKET FOR DEVICE CONTEXT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 150 AI IN HEALTHCARE MARKET FOR USER CONTEXT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 151 AI IN HEALTHCARE MARKET FOR PHYSICAL CONTEXT, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 152 AI IN HEALTHCARE MARKET FOR GENERATIVE AI, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 153 AI IN HEALTHCARE MARKET FOR COMPUTER VISION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 154 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 155 AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 156 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 157 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 158 AI IN HEALTHCARE MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 159 AI IN HEALTHCARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 160 AI IN HEALTHCARE MARKET FOR HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 161 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 162 AI IN HEALTHCARE MARKET FOR PHARMACIES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 163 AI IN HEALTHCARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 164 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 165 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 166 AI IN HEALTHCARE MARKET FOR PUBLIC PAYERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 167 AI IN HEALTHCARE MARKET FOR PRIVATE PAYERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 168 AI IN HEALTHCARE MARKET FOR PATIENTS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 169 AI IN HEALTHCARE MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 170 AI IN HEALTHCARE MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 171 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 172 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 173 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 174 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 175 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 176 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 177 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 178 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 179 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 180 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 181 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 182 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 183 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 184 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 185 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 186 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 187 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 188 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 189 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 190 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 191 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 192 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 193 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 194 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 195 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 196 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 197 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 198 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 199 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 200 US: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 201 US: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 202 US: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 203 US: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 204 US: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 205 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 206 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 207 US: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 208 US: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 209 US: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 210 US: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 211 US: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 212 US: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 213 US: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 214 US: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 215 US: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 216 US: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 217 US: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 218 US: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 219 US: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 220 US: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 221 US: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 222 US: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 223 US: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 224 US: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 225 US: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 226 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 227 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 228 CANADA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 229 CANADA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 230 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 231 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 232 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 233 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 234 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 235 CANADA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 236 CANADA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 237 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 238 CANADA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 239 CANADA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 240 CANADA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 241 CANADA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 242 CANADA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 243 CANADA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 244 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 245 CANADA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 246 CANADA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 247 CANADA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 248 CANADA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 249 CANADA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 250 CANADA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 251 CANADA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 252 CANADA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 253 CANADA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 254 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 255 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 256 EUROPE: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 257 EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 258 EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 259 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 260 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 261 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 262 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 263 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 264 EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 265 EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 266 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 267 EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 268 EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 269 EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 270 EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 271 EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 272 EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 273 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 274 EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 275 EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 276 EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 277 EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 278 EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 279 EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 280 EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 281 EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 282 EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 283 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 284 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 285 GERMANY: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 286 GERMANY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 287 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 288 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 289 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 290 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 291 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 292 GERMANY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 293 GERMANY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 294 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 295 GERMANY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 296 GERMANY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 297 GERMANY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 298 GERMANY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 299 GERMANY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 300 GERMANY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 301 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 302 GERMANY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 303 GERMANY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 304 GERMANY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 305 GERMANY: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 306 GERMANY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 307 GERMANY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 308 GERMANY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 309 GERMANY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 310 GERMANY: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 311 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 312 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 313 UK: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 314 UK: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 315 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 316 UK: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 317 UK: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 318 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 319 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 320 UK: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 321 UK: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 322 UK: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 323 UK: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 324 UK: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 325 UK: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 326 UK: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 327 UK: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 328 UK: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 329 UK: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 330 UK: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 331 UK: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 332 UK: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 333 UK: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 334 UK: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 335 UK: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 336 UK: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 337 UK: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 338 UK: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 339 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 340 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 341 FRANCE: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 342 FRANCE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 343 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 344 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 345 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 346 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 347 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 348 FRANCE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 349 FRANCE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 350 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 351 FRANCE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 352 FRANCE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 353 FRANCE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 354 FRANCE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 355 FRANCE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 356 FRANCE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 357 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 358 FRANCE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 359 FRANCE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 360 FRANCE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 361 FRANCE: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 362 FRANCE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 363 FRANCE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 364 FRANCE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 365 FRANCE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 366 FRANCE: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 367 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 368 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 369 ITALY: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 370 ITALY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 371 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 372 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 373 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 374 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 375 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 376 ITALY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 377 ITALY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 378 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 379 ITALY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 380 ITALY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 381 ITALY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 382 ITALY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 383 ITALY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 384 ITALY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 385 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 386 ITALY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 387 ITALY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 388 ITALY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 389 ITALY: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 390 ITALY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 391 ITALY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 392 ITALY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 393 ITALY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 394 ITALY: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 395 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 396 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 397 SPAIN: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 398 SPAIN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 399 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 400 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 401 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 402 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 403 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 404 SPAIN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 405 SPAIN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 406 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 407 SPAIN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 408 SPAIN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 409 SPAIN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 410 SPAIN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 411 SPAIN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 412 SPAIN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 413 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 414 SPAIN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 415 SPAIN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 416 SPAIN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 417 SPAIN: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 418 SPAIN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 419 SPAIN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 420 SPAIN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 421 SPAIN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 422 SPAIN: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 423 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 424 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 425 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 426 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 427 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 428 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 429 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 430 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 431 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 432 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 433 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 434 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 435 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 436 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 437 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 438 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 439 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 440 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 441 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 442 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 443 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 444 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 445 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 446 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 447 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 448 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 449 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 450 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 451 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 452 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 453 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 454 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 455 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 456 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 457 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 458 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 459 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 460 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 461 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 462 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 463 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 464 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 465 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 466 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 467 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 468 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 469 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 470 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 471 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 472 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 473 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 474 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 475 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 476 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 477 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 478 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 479 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 480 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 481 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 482 CHINA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 483 CHINA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 484 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 485 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 486 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 487 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 488 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 489 CHINA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 490 CHINA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 491 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 492 CHINA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 493 CHINA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 494 CHINA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 495 CHINA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 496 CHINA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 497 CHINA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 498 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 499 CHINA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 500 CHINA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 501 CHINA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 502 CHINA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 503 CHINA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 504 CHINA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 505 CHINA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 506 CHINA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 507 CHINA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 508 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 509 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 510 JAPAN: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 511 JAPAN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 512 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 513 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 514 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 515 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 516 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 517 JAPAN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 518 JAPAN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 519 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 520 JAPAN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 521 JAPAN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 522 JAPAN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 523 JAPAN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 524 JAPAN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 525 JAPAN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 526 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 527 JAPAN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 528 JAPAN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 529 JAPAN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 530 JAPAN: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 531 JAPAN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 532 JAPAN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 533 JAPAN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 534 JAPAN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 535 JAPAN: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 536 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 537 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 538 INDIA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 539 INDIA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 540 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 541 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 542 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 543 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 544 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 545 INDIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 546 INDIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 547 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 548 INDIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 549 INDIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 550 INDIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 551 INDIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 552 INDIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 553 INDIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 554 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 555 INDIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 556 INDIA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 557 INDIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 558 INDIA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 559 INDIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 560 INDIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 561 INDIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 562 INDIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 563 INDIA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 564 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 565 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 566 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 567 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 568 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 569 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 570 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 571 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 572 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 573 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 574 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 575 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 576 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 577 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 578 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 579 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 580 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 581 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 582 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 583 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 584 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 585 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 586 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 587 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 588 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 589 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 590 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 591 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 592 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 593 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 594 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 595 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 596 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 597 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 598 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 599 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 600 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 601 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 602 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 603 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 604 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 605 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 606 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 607 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 608 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 609 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 610 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 611 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 612 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 613 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 614 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 615 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 616 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 617 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 618 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 619 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 620 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 621 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 622 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 623 BRAZIL: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 624 BRAZIL: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 625 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 626 BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 627 BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 628 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 629 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 630 BRAZIL: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 631 BRAZIL: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 632 BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 633 BRAZIL: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 634 BRAZIL: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 635 BRAZIL: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 636 BRAZIL: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 637 BRAZIL: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 638 BRAZIL: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 639 BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 640 BRAZIL: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 641 BRAZIL: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 642 BRAZIL: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 643 BRAZIL: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 644 BRAZIL: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 645 BRAZIL: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 646 BRAZIL: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 647 BRAZIL: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 648 BRAZIL: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 649 BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 650 BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 651 MEXICO: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 652 MEXICO: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 653 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 654 MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 655 MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 656 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 657 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 658 MEXICO: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 659 MEXICO: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 660 MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 661 MEXICO: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 662 MEXICO: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 663 MEXICO: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 664 MEXICO: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 665 MEXICO: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 666 MEXICO: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 667 MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 668 MEXICO: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 669 MEXICO: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 670 MEXICO: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 671 MEXICO: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 672 MEXICO: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 673 MEXICO: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 674 MEXICO: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 675 MEXICO: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 676 MEXICO: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 677 MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 678 MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE 2022–2030 (USD MILLION)
  • TABLE 679 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 680 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 681 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 682 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 683 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 684 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 685 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 686 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 687 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 688 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 689 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 690 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 691 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 692 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 693 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 694 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 695 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 696 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 697 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 698 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 699 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 700 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 701 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 702 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 703 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 704 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 705 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 706 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 707 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 708 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 709 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 710 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 711 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 712 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 713 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 714 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 715 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 716 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 717 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 718 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 719 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 720 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 721 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 722 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 723 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 724 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 725 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 726 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 727 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 728 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 729 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 730 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 731 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 732 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 733 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 734 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 735 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 736 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 737 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 738 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 739 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 740 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 741 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 742 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 743 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 744 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 745 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 746 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 747 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 748 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 749 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 750 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 751 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 752 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 753 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 754 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 755 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 756 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 757 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 758 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 759 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 760 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 761 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 762 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 763 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 764 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)
  • TABLE 765 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)
  • TABLE 766 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 767 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)
  • TABLE 768 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 769 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 770 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)
  • TABLE 771 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 772 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 773 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 774 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 775 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 776 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 777 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 778 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 779 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 780 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 781 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 782 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 783 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)
  • TABLE 784 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)
  • TABLE 785 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 786 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 787 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 788 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 789 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 790 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 791 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)
  • TABLE 792 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET, JANUARY 2021–NOVEMBER 2024
  • TABLE 793 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE ANALYSIS, 2023
  • TABLE 794 AI IN HEALTHCARE MARKET: REGION FOOTPRINT
  • TABLE 795 AI IN HEALTHCARE MARKET: APPLICATION FOOTPRINT
  • TABLE 796 AI IN HEALTHCARE MARKET: TOOL FOOTPRINT
  • TABLE 797 AI IN HEALTHCARE MARKET: FUNCTION FOOTPRINT
  • TABLE 798 AI IN HEALTHCARE MARKET: OFFERING FOOTPRINT
  • TABLE 799 AI IN HEALTHCARE MARKET: DEPLOYMENT FOOTPRINT
  • TABLE 800 AI IN HEALTHCARE MARKET: END-USER FOOTPRINT
  • TABLE 801 AI IN HEALTHCARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 802 AI IN HEALTHCARE MARKET: REGION FOOTPRINT (STARTUPS/SMES)
  • TABLE 803 AI IN HEALTHCARE MARKET: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 804 AI IN HEALTHCARE MARKET: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 805 AI IN HEALTHCARE MARKET: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024
  • TABLE 806 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 807 KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES OFFERED
  • TABLE 808 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 809 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 810 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
  • TABLE 811 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024
  • TABLE 812 MICROSOFT CORPORATION: COMPANY OVERVIEW
  • TABLE 813 MICROSOFT CORPORATION: PRODUCTS & SERVICES OFFERED
  • TABLE 814 MICROSOFT CORPORATION: PRODUCT LAUNCHES,JANUARY 2021–NOVEMBER 2024
  • TABLE 815 MICROSOFT CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 816 NVIDIA CORPORATION: COMPANY OVERVIEW
  • TABLE 817 NVIDIA CORPORATION: PRODUCTS & SERVICES OFFERED
  • TABLE 818 NVIDIA CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 819 NVIDIA CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 820 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 821 SIEMENS HEALTHINEERS AG: PRODUCTS & SERVICES OFFERED
  • TABLE 822 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–NOVEMBER 2024
  • TABLE 823 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 824 SIEMENS HEALTHINEERS AG: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024
  • TABLE 825 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 826 GE HEALTHCARE: PRODUCTS & SERVICES OFFERED
  • TABLE 827 GE HEALTHCARE: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 828 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 829 EPIC SYSTEMS CORPORATION: PRODUCTS & SERVICES OFFERED
  • TABLE 830 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 831 ORACLE: COMPANY OVERVIEW
  • TABLE 832 ORACLE: PRODUCTS & SERVICES OFFERED
  • TABLE 833 ORACLE: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
  • TABLE 834 ORACLE: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 835 VERADIGM LLC: COMPANY OVERVIEW
  • TABLE 836 VERADIGM LLC: PRODUCTS & SERVICES OFFERED
  • TABLE 837 VERADIGM LLC: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 838 AMAZON WEB SERVICES, INC.: COMPANY OVERVIEW
  • TABLE 839 AMAZON WEB SERVICES, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 840 AMAZON WEB SERVICES, INC.: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
  • TABLE 841 AMAZON WEB SERVICES, INC.: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 842 IBM: COMPANY OVERVIEW
  • TABLE 843 MERATIVE: PRODUCTS & SERVICES OFFERED
  • TABLE 844 MERATIVE: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 845 MERATIVE: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 846 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 847 MEDTRONIC: PRODUCTS & SERVICES OFFERED
  • TABLE 848 MEDTRONIC: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 849 GOOGLE: COMPANY OVERVIEW
  • TABLE 850 GOOGLE: PRODUCTS & SERVICES OFFERED
  • TABLE 851 GOOGLE: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 852 GOOGLE: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 853 GOOGLE: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024
  • TABLE 854 SOPHIA GENETICS: COMPANY OVERVIEW
  • TABLE 855 SOPHIA GENETICS: PRODUCTS & SERVICES OFFERED
  • TABLE 856 SOPHIA GENETICS: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 857 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
  • TABLE 858 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 859 JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 860 TEMPUS: COMPANY OVERVIEW
  • TABLE 861 TEMPUS: PRODUCTS & SERVICES OFFERED
  • TABLE 862 TEMPUS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 863 TEMPUS: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 864 CONCERTAI: COMPANY OVERVIEW
  • TABLE 865 CONCERTAI: PRODUCTS & SERVICES OFFERED
  • TABLE 866 CONCERTAI: PRODUCT LAUNCHES & UPGRADES, JANUARY 2021–NOVEMBER 2024
  • TABLE 867 CONCERTAI: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 868 3M: COMPANY OVERVIEW
  • TABLE 869 3M: PRODUCTS & SERVICES OFFERED
  • TABLE 870 3M: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 871 COGNIZANT: COMPANY OVERVIEW
  • TABLE 872 COGNIZANT: PRODUCTS & SERVICES OFFERED
  • TABLE 873 COGNIZANT: PRODUCT LAUNCHES & UPGRADES, JANUARY 2021–NOVEMBER 2024
  • TABLE 874 COGNIZANT: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 875 VIZ.AI, INC.: COMPANY OVERVIEW
  • TABLE 876 VIZ.AI, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 877 VIZ.AI, INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 878 VIZ.AI, INC.: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 879 VIZ.AI, INC.: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024
  • TABLE 880 RIVERAIN TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 881 RIVERAIN TECHNOLOGIES: PRODUCTS & SERVICES OFFERED
  • TABLE 882 RIVERAIN TECHNOLOGIES: DEALS, JANUARY 2021–NOVEMBER 2024
LIST OF FIGURES
 
  • FIGURE 1 AI IN HEALTHCARE MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 6 BOTTOM-UP APPROACH: END-USER SPENDING ON AI IN HEALTHCARE
  • FIGURE 7 AI IN HEALTHCARE MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030)
  • FIGURE 8 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
  • FIGURE 9 TOP-DOWN APPROACH
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 AI IN HEALTHCARE MARKET, BY OFFERING, 2024 VS. 2030 (USD MILLION)
  • FIGURE 12 AI IN HEALTHCARE MARKET, BY FUNCTION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 13 AI IN HEALTHCARE MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 14 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024 VS. 2030 (USD MILLION)
  • FIGURE 15 AI IN HEALTHCARE MARKET, BY TOOL, 2024 VS. 2030 (USD MILLION)
  • FIGURE 16 AI IN HEALTHCARE MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • FIGURE 17 AI IN HEALTHCARE MARKET: REGIONS COVERED
  • FIGURE 18 RISING NEED FOR EARLY DISEASE DETECTION TO DRIVE MARKET
  • FIGURE 19 JAPAN TO DOMINATE MARKET IN ASIA PACIFIC IN 2024
  • FIGURE 20 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 21 NORTH AMERICA TO DOMINATE AI IN HEALTHCARE MARKET DURING FORECAST PERIOD
  • FIGURE 22 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 23 AI IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 DATA BREACHES IN HEALTHCARE SECTOR, 2019–2023
  • FIGURE 25 CHALLENGES ASSOCIATED WITH HEALTHCARE DATA INTEROPERABILITY
  • FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • FIGURE 27 AI IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 28 AI IN HEALTHCARE MARKET: ECOSYSTEM MAPPING
  • FIGURE 29 AI IN HEALTHCARE MARKET: PATENTS GRANTED, 2013–2023
  • FIGURE 30 AI IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 33 AI IN HEALTHCARE MARKET: INVESTMENT & FUNDING SCENARIO, 2024
  • FIGURE 34 GEN AI USE CASES IN HEALTHCARE
  • FIGURE 35 NORTH AMERICA: AI IN HEALTHCARE MARKET SNAPSHOT
  • FIGURE 36 EUROPE: AI IN HEALTHCARE MARKET SNAPSHOT
  • FIGURE 37 ASIA PACIFIC: AI IN HEALTHCARE MARKET SNAPSHOT
  • FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2019–2023
  • FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2023
  • FIGURE 40 RANKING OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2023
  • FIGURE 41 AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 42 AI IN HEALTHCARE MARKET: COMPANY FOOTPRINT
  • FIGURE 43 AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 44 EV/EBITDA OF KEY VENDORS
  • FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 46 AI IN HEALTHCARE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 47 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
  • FIGURE 48 MICROSOFT CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 49 NVIDIA CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 50 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 52 ORACLE: COMPANY SNAPSHOT (2023)
  • FIGURE 53 VERADIGM LLC: COMPANY SNAPSHOT (2021)
  • FIGURE 54 AMAZON WEB SERVICES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 55 IBM: COMPANY SNAPSHOT (2023)
  • FIGURE 56 MEDTRONIC: COMPANY SNAPSHOT (2023)
  • FIGURE 57 GOOGLE: COMPANY SNAPSHOT (2023)
  • FIGURE 58 SOPHIA GENETICS: COMPANY SNAPSHOT (2023)
  • FIGURE 59 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 60 3M: COMPANY SNAPSHOT (2023)
  • FIGURE 61 COGNIZANT: COMPANY SNAPSHOT (2023)

 

The study involved significant activities to estimate the current size of the Artificial Intelligence (AI) in healthcare market. Exhaustive secondary research was done to collect information on the Artificial Intelligence (AI) in healthcare market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the Artificial Intelligence (AI) in healthcare market.

Secondary Research

This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for the companies offering Artificial Intelligence (AI) in healthcare solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.

Various secondary sources were referred to in the secondary research process to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of Artificial Intelligence (AI) in healthcare vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

Primary research was conducted to identify segmentation types; industry trends; key players; and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies adopted by key players.

After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at.

In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

Breakdown of the Primary Respondents:

Artificial Intelligence (AI) in Healthcare Market

*Others include sales managers, marketing managers, and product managers.

Note: Tiers are defined based on a company’s total revenue, as of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by offering, function, application, deployment, tools, end user, and region).

Artificial Intelligence (AI) in Healthcare Market

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Artificial Intelligence (AI) in healthcare market.

Market Definition

Artificial Intelligence (AI) in healthcare market encompasses the application of artificial intelligence technologies, such as machine learning, natural language processing, computer vision, and robotics, to improve healthcare delivery, enhance operational efficiencies, and provide personalized care. These solutions address a wide range of use cases, including diagnostic imaging, predictive analytics, drug discovery, patient engagement, remote monitoring, and administrative workflows, enabling healthcare providers, payers, and pharmaceutical companies to drive innovation and improve outcomes.

Stakeholders

  • Artificial Intelligence (AI) in healthcare software vendors
  • Artificial Intelligence (AI) in healthcare service providers
  • Independent software vendors (ISVs)
  • Platform providers
  • Technology providers
  • System integrators
  • Cloud service providers
  • Healthcare IT service providers
  • Hospitals and surgical centers
  • Diagnostic imaging centers
  • Academic institutes and research laboratories
  • Forums, alliances, and associations
  • Government organizations
  • Institutional investors and investment banks
  • Investors/Shareholders
  • Venture capitalists
  • Research and consulting firms

Report Objectives

  • To define, describe, and forecast the global Artificial Intelligence (AI) in healthcare market based on offering, function, application, deployment, tools, end user, and region
  • To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall Artificial Intelligence (AI) in healthcare market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the Artificial Intelligence (AI) in healthcare market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
  • To track and analyze competitive developments such as product & service launches; expansions; partnerships, agreements, and collaborations; and acquisitions in the Artificial Intelligence (AI) in healthcare market
  • To benchmark players within the Artificial Intelligence (AI) in healthcare market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

Previous Versions of this Report

Artificial Intelligence (AI) in Healthcare Market by Offering (Hardware, Software, Services), Technology (Machine Learning, Natural Language Processing), Application (Medical Imaging & Diagnostics, Patient Data & Risk Analysis), End User & Region - Global Forecast to 2029

Report Code SE 5225
Published in Jan, 2024, By MarketsandMarkets™

Artificial Intelligence in Healthcare Market by Offering (Hardware, Software, Services), Technology (Machine Learning, NLP, Context-aware Computing, Computer Vision), Application, End User and Region - Global Forecast to 2028

Report Code SE 5225
Published in Jan, 2023, By MarketsandMarkets™

Artificial Intelligence in Healthcare Market by Offering (Hardware, Software, Services), Technology (Machine Learning, NLP, Context-aware Computing, Computer Vision), Application, End User and Geography - Global Forecast to 2027

Report Code SE 5225
Published in Oct, 2021, By MarketsandMarkets™

Artificial Intelligence in Healthcare Market with Covid-19 Impact Analysis by Offering (Hardware, Software, Services), Technology (Machine Learning, NLP, Context-Aware Computing, Computer Vision), End-Use Application, End User and Region - Global Forecast to 2026

Report Code SE 5225
Published in Jun, 2020, By MarketsandMarkets™

Artificial Intelligence in Healthcare Market by Offering (Hardware, Software, Services), Technology (Machine Learning, NLP, Context-Aware Computing, Computer Vision), End-Use Application, End User, and Geography – Global Forecast to 2025

Report Code SE 5225
Published in Dec, 2018, By MarketsandMarkets™

Artificial Intelligence in Healthcare Market by Offering (Hardware, Software, Services), Technology (Machine Learning, NLP, Context-Aware Computing, Computer Vision), End-Use Application, End User, and Geography – Global Forecast to 2025

Report Code SE 5225
Published in May, 2017, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Artificial Intelligence (AI) in Healthcare Market

winsay

May, 2022

Interested about how AI will change the treatment process and its benefits. .

Payush

Nov, 2017

I was going through the ToC of AI in Healthcare market, I would like to understand, what are the requirements to perform in the fields of AI? .

Payush

Nov, 2017

I was going through the ToC of AI in Healthcare market, I would like to understand, what are the requirements to perform in the fields of AI? .

Riju

Dec, 2018

We have specific interests in global AI in healthcare market and the US AI in healthcare market. Any further details related to market size of AI for early disease detection (for global and USA) would be appreciated. .

Asghar

Feb, 2019

I am looking to purchase this report to see the implications of AI on the workforce in Norway..

Tanuj

May, 2019

I am interested in understanding the market size and related insights on computer-assisted physician documentation (CAPD), clinical documentation improvement (CDI), computer-assisted coding (CAC), ambient voice and voice assistants, NLP, and machine learning for clinical, operational, and financial healthcare scenarios in AI in healthcare..

Narayan

Dec, 2019

I am an automation enthusiast and would like to understand the impact of AI in healthcare. Could you provide me some brochure and sample to get into details..

Kevin

May, 2019

I am conducting a research project on AI in healthcare as a part of my MHA/MBA marketing course. Could you share some relevant information in the form of sample brochure and estimated cost of the report, post discount mentioned on the website?.

Vishal

Feb, 2019

We are redeveloping our chart for Artificial Intelligence in Healthcare Market. Does your report covers regional market insights..

Show More
DMCA.com Protection Status